Literature DB >> 9539023

DNA-dependent protein kinase does not play a role in adaptive survival responses to ionizing radiation.

E Odegaard1, C R Yang, D A Boothman.   

Abstract

We previously demonstrated that exposure of certain human tumor cells to very low chronic doses of ionizing radiation led to their enhanced survival following exposure to subsequent high doses of radiation. Survival enhancement due to these adaptive survival responses (ASRs) ranged from 1.5-fold to 2.2-fold in many human tumor cells. Furthermore, we showed that ASRs result from altered G1 checkpoint regulation, possibly mediated by overexpression of cyclin D1, proliferating cell nuclear antigen (PCNA), and the X-ray induction of cyclin A. Because cyclin D1 and PCNA proteins are components of many DNA synthetic and repair processes in the cell, we tested the hypothesis that preexposure of cells to low doses of ionizing radiation enabled activation of the DNA repair machinery needed for survival recovery after high-dose radiation. We examined the role of DNA break repair in ASRs using murine cells deficient (i.e., severe combined immunodeficiency [SCID] cells) or proficient (i.e., parental mouse strain [CB-17] cells) in DNA-dependent protein kinase catalytic subunit (DNA-PKcs) expression and DNA double-strand break repair, DNA-PKcs is a nuclear serine/threonine protein kinase that is activated by DNA breaks and plays a key role in double-strand break repair. DNA-PKcs also phosphorylates several nuclear DNA-binding regulatory transcription factor proteins (e.g., Sp1 and p53), which suggests that DNA-PKcs may play a role in regulating transcription, replication, and recombination as well as DNA repair, after radiation. Therefore, we exposed confluent SCID or CB-17 cells to low priming doses of ionizing radiation (i.e., 5 cGy) and compared the survival responses of primed cells to those of unprimed cells after an equitoxic high-dose challenge. Low-dose-primed SCID or CB-17 cells demonstrated 2-fold enhanced survival after a high-dose challenge compared to that of unprimed control cells. These data suggest that expression of the catalytic subunit of DNA-PKcs (expressed in CB-17 not SCID cells) and the presence of active double-strand break repair processes (active in CB-17, deficient in SCID cells) do not play a major role in ASRs in mammalian cells. Furthermore, we present data that suggest that DNA-PKcs plays a role in the regulation of the G2/M cell cycle checkpoint following extremely high doses of ionizing radiation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9539023      PMCID: PMC1533273          DOI: 10.1289/ehp.98106s1301

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  19 in total

1.  Cancer. p53, guardian of the genome.

Authors:  D P Lane
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

2.  Evidence that the adaptive response of human lymphocytes to ionizing radiation acts on lethal damage in nonaberrant cells.

Authors:  J D Shadley; G Dai
Journal:  Mutat Res       Date:  1993-03       Impact factor: 2.433

3.  The human DNA-activated protein kinase phosphorylates simian virus 40 T antigen at amino- and carboxy-terminal sites.

Authors:  Y R Chen; S P Lees-Miller; P Tegtmeyer; C W Anderson
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

4.  Identification and characterization of X-ray-induced proteins in human cells.

Authors:  D A Boothman; I Bouvard; E N Hughes
Journal:  Cancer Res       Date:  1989-06-01       Impact factor: 12.701

5.  Cytogenetic and survival adaptive responses in G1 phase human lymphocytes.

Authors:  J D Shadley; G Q Dai
Journal:  Mutat Res       Date:  1992-02       Impact factor: 2.433

6.  Adaptive response of human lymphocytes for the repair of radon-induced chromosomal damage.

Authors:  S Wolff; R Jostes; F T Cross; T E Hui; V Afzal; J K Wiencke
Journal:  Mutat Res       Date:  1991 Sep-Oct       Impact factor: 2.433

7.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.

Authors:  M B Kastan; Q Zhan; W S el-Deiry; F Carrier; T Jacks; W V Walsh; B S Plunkett; B Vogelstein; A J Fornace
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

8.  Complementation of the radiosensitive phenotype in severe combined immunodeficient mice by human chromosome 8.

Authors:  C U Kirchgessner; L M Tosto; K A Biedermann; M Kovacs; D Araujo; E J Stanbridge; J M Brown
Journal:  Cancer Res       Date:  1993-12-15       Impact factor: 12.701

9.  Potentiation of halogenated pyrimidine radiosensitizers in human carcinoma cells by beta-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran- 5,6-dione), a novel DNA repair inhibitor.

Authors:  D A Boothman; S Greer; A B Pardee
Journal:  Cancer Res       Date:  1987-10-15       Impact factor: 13.312

10.  Inhibition of radiation-induced neoplastic transformation by beta-lapachone.

Authors:  D A Boothman; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 12.779

View more
  2 in total

1.  Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virus.

Authors:  Subhash C Verma; Bharat G Bajaj; Qiliang Cai; Huaxin Si; Todd Seelhammer; Erle S Robertson
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

Review 2.  Advances in the study of HSP70 inhibitors to enhance the sensitivity of tumor cells to radiotherapy.

Authors:  Sihan Du; Ying Liu; Yuan Yuan; Yuran Wang; Yanfang Chen; Shuai Wang; Yuhua Chi
Journal:  Front Cell Dev Biol       Date:  2022-08-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.